Back to search
Infantile Malignant Osteopetrosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infantile Malignant Osteopetrosis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Infantile Malignant Osteopetrosis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This single-institution, phase II study is designed to test the ability to achieve donor hematopoietic engraftment while maintaining low rates of transplant-rel…
The primary objective of this Phase 1 study is to evaluate the therapeutic safety and feasibility of the investigational product (IP), RP-L401.
The purpose of this research is to explore what we believe may be a safer and more effective means of performing stem cell transplantation in patients with Oste…
We believe that hematopoietic stem cell transplantation (HSCT) will help subjects with Osteopetrosis generate functioning osteoclasts, and by so doing assist in…
The purpose of this study is to evaluate the efficacy and side effects of donor hematopoietic cells using chemotherapy regimen without total-body irradiation in…